Nutra is the vertical of health, beauty and weight-loss products; the glossary entry nutra explains it. You are paid for a confirmed order, not for a click, so in nutra the payout comes down to the approval rate. Networks with nutra offers are in the nutra slice, offer exports are in NeNutra.
Running nutra on Facebook
Facebook is still the mass source for nutra: flexible targeting and large volume. The price is strict moderation. Physical-goods offers sit on the edge of the platform’s rules, so the work goes through farmed accounts, prelanders and moderation workarounds. This is a grey vertical; see white and grey verticals.
Native ads and push for nutra
Native (teaser) networks give cheap volume and an older audience, and for weight-loss and joint-care offers that often works better than social media. Quality is lower than on Facebook, but moderation is softer. Push is cheaper still and broader still.
Nutra GEOs
Nutra runs worldwide: Europe, Latin America, Asia, the CIS. The choice of GEO is tied to the payment format: prepayment in some places, COD (cash on delivery) in others. COD GEOs give cheap leads but a lot of work for the call center.
Approval rate and the call center
In COD nutra the user leaves an order request and the advertiser’s call center confirms the order. A low approval rate cuts your payout even when leads keep coming: a request is not money yet. The approval rate depends on the GEO, the offer and the quality of your traffic, not only on the call center.
Funnel examples
A nutra funnel is “source + prelander + offer + GEO”; the glossary entry funnel explains the term. We don’t give figures like “spent this much, made that much”: public case studies are embellished, and someone else’s result doesn’t repeat.
How to read someone else’s case study: look at the funnel and the GEO, not the amount. In nutra the outcome depends heavily on the call center’s approval rate, and yours will be different. What carries over is the approach (the source, the prelander angle, the offer for the GEO), not the claimed profit.